Skip to main content
. 2021 Oct 21;18(10):e1003807. doi: 10.1371/journal.pmed.1003807

Table 1. Cohort characteristics and incidence of SARS-CoV-2 infection presented by month in a cohort of 9.1 million VA enrollees followed from February 2020 to March 2021.

Cohort characteristics
N (%)
Number of SARS-CoV-2–positive persons (and incidence per 10,000 persons per month)
Time period and number of VA enrollees at risk* Entire period: February 2020 to March 2021
N = 9,127,673
February to March 2020
N = 9,127,673
April 2020
N = 9,090,196
May 2020
N = 9,053,082
June 2020
N = 9,022,051
July 2020
N = 8,990,833
August 2020
N = 8,948,674
September 2020
N = 8,913,864
October 2020
N = 8,881,573
November 2020
N = 8,844,680
December 2020
N = 8,804,424
January 2021
N = 8,744,388
February 2021
N = 8,671,916
March 2021
N = 8,630,283
All persons infected 216,046
(100%)
2,470
(2.7)
7,346
(8.1)
4,957
(5.5)
7,634
(8.5)
16,105
(17.9)
9,189
(10.3)
7,526
(8.4)
13,523
(15.2)
33,553
(37.9)
47,357
(53.8)
39,431
(45.1)
17,698
(20.4)
9,257
(10.7)
Sex
Female 829,355
(9.1)
218
(2.6)
695
(8.4)
453
(5.5)
853
(10.3)
1,946
(23.6)
968
(11.8)
716
(8.7)
1,243
(15.2)
3,315
(40.6)
4,859
(59.7)
3,942
(48.7)
1,825
(22.7)
1,003
(12.5)
Male 8,298,318
(90.9)
2,252
(2.7)
6,651
(8.1)
4,504
(5.5)
6,781
(8.3)
14,159
(17.3)
8,221
(10.1)
6,810
(8.4)
12,280
(15.2)
30,238
(37.7)
42,498
(53.2)
35,489
(44.7)
15,873
(20.2)
8,254
(10.5)
Age (years)
18 to 24 81,085
(0.9)
8
(1.0)
26
(3.2)
16
(2.0)
88
(10.9)
153
(18.9)
66
(8.2)
42
(5.2)
69
(8.6)
207
(25.7)
303
(37.7)
229
(28.6)
86
(10.8)
59
(7.4)
25 to 34 828,607
(9.1)
144
(1.7)
388
(4.7)
273
(3.3)
919
(11.1)
1,681
(20.3)
737
(8.9)
538
(6.5)
993
(12.1)
2,648
(32.2)
3,633
(44.3)
2,745
(33.6)
1,220
(15.0)
767
(9.4)
35 to 44 1,069,496
(11.7)
279
(2.6)
614
(5.7)
405
(3.8)
1,005
(9.4)
2,168
(20.3)
1,018
(9.6)
794
(7.5)
1,488
(14.0)
3,898
(36.7)
5,409
(51.2)
4,382
(41.7)
1,879
(17.9)
1,205
(11.5)
45 to 54 1,175,283
(12.9)
369
(3.1)
860
(7.3)
546
(4.7)
1,174
(10.0)
2,708
(23.1)
1,364
(11.7)
1,103
(9.5)
1,952
(16.8)
4,938
(42.5)
6,790
(58.7)
5,524
(48.1)
2,455
(21.5)
1,496
(13.1)
55 to 64 1,517,143
(16.6)
562
(3.7)
1,514
(10.0)
1,061
(7.0)
1,420
(9.4)
3,086
(20.5)
1,810
(12.1)
1,385
(9.3)
2,506
(16.8)
6,093
(40.9)
8,846
(59.7)
7,579
(51.5)
3,478
(23.8)
1,927
(13.2)
65 to 74 2,434,839
(26.7)
688
(2.8)
2,111
(8.7)
1,399
(5.8)
1,808
(7.5)
3,989
(16.6)
2,554
(10.7)
2,215
(9.3)
3,938
(16.6)
9,484
(40.1)
13,197
(56.1)
11,319
(48.5)
5,167
(22.3)
2,355
(10.2)
75 to 84 1,257,097
(13.8)
279
(2.2)
1,022
(8.2)
693
(5.6)
795
(6.5)
1,564
(12.8)
1,123
(9.2)
999
(8.3)
1,797
(15.0)
4,389
(36.8)
6,368
(53.7)
5,380
(45.7)
2,384
(20.5)
1,050
(9.1)
≥85 764,123
(8.4)
141
(1.8)
811
(10.8)
564
(7.7)
425
(5.9)
756
(10.6)
517
(7.3)
450
(6.5)
780
(11.4)
1,896
(28.0)
2,811
(41.9)
2,273
(34.2)
1,029
(15.9)
398
(6.2)
Race
White 5,886,250
(64.5)
956
(1.6)
3,774
(6.4)
2,739
(4.7)
4,414
(7.6)
9,315
(16.1)
5,690
(9.9)
5,141
(9.0)
9,898
(17.3)
24,753
(43.5)
33,126
(58.5)
26,626
(47.4)
11,932
(21.4)
6,425
(11.6)
Black 1,337,163
(14.6)
1,293
(9.7)
2,919
(21.9)
1,729
(13.0)
2,319
(17.6)
4,922
(37.4)
2,544
(19.4)
1,602
(12.3)
2,267
(17.4)
5,337
(41.2)
8,959
(69.5)
8,488
(66.4)
3,909
(30.8)
1,914
(15.2)
Asian 114,794
(1.3)
27
(2.4)
55
(4.8)
37
(3.2)
75
(6.6)
168
(14.7)
81
(7.1)
70
(6.2)
95
(8.4)
278
(24.6)
550
(48.8)
442
(39.4)
191
(17.1)
82
(7.4)
AI/AN 79,738
(0.9)
14
(1.8)
54
(6.8)
48
(6.1)
92
(11.6)
155
(19.7)
79
(10.1)
76
(9.7)
147
(18.9)
340
(43.9)
439
(56.9)
349
(45.6)
162
(21.3)
60
(7.9)
PI/NH 75,186
(0.8)
13
(1.7)
57
(7.6)
44
(5.9)
77
(10.3)
157
(21.1)
101
(13.7)
73
(9.9)
115
(15.7)
301
(41.1)
440
(60.4)
393
(54.3)
177
(24.7)
68
(9.5)
Missing/unknown/refused 1,634,542
(17.9)
167
(1.0)
487
(3.0)
360
(2.2)
657
(4.1)
1,388
(8.6)
694
(4.3)
564
(3.5)
1,001
(6.3)
2,544
(16.0)
3,843
(24.2)
3,133
(19.8)
1,327
(8.4)
708
(4.5)
Ethnicity
Non-Hispanic 7,201,109
(78.9)
2,119
(2.9)
6,441
(9.0)
4,365
(6.1)
6,101
(8.6)
12,936
(18.3)
7,825
(11.1)
6,615
(9.4)
11,868
(17.0)
29,477
(42.3)
40,749
(58.8)
33,980
(49.4)
15,482
(22.7)
8,014
(11.8)
Hispanic 571,236
(6.3)
272
(4.8)
649
(11.4)
426
(7.5)
1,235
(21.8)
2,583
(45.7)
1,037
(18.5)
645
(11.5)
1,159
(20.8)
2,819
(50.7)
4,648
(84.1)
3,791
(69.2)
1,487
(27.4)
861
(15.9)
Missing/unknown/refused 1,355,328
(14.8)
79
(0.6)
256
(1.9)
166
(1.2)
298
(2.2)
586
(4.4)
327
(2.4)
266
(2.0)
496
(3.7)
1,257
(9.5)
1,960
(14.8)
1,660
(12.6)
729
(5.6)
382
(2.9)
US Federal Region
1 400,339
(4.4)
95
(2.4)
852
(21.4)
398
(10.1)
196
(5.0)
143
(3.6)
102
(2.6)
99
(2.5)
219
(5.6)
946
(24.5)
1,674
(43.4)
1,520
(39.7)
760
(20.0)
419
(11.1)
2 665,463
(7.3)
615
(9.2)
1,717
(26.0)
590
(9.0)
267
(4.1)
340
(5.2)
217
(3.4)
209
(3.2)
380
(5.9)
1,248
(19.5)
2,183
(34.2)
2,114
(33.3)
1,079
(17.1)
759
(12.1)
3 958,643
(10.5)
185
(1.9)
838
(8.8)
657
(6.9)
459
(4.8)
773
(8.2)
581
(6.2)
474
(5.1)
830
(8.9)
2,528
(27.1)
4,474
(48.2)
3,725
(40.4)
1,815
(19.8)
1,048
(11.5)
4 2,290,207
(25.1)
363
(1.6)
1,085
(4.8)
1,006
(4.4)
2,474
(10.9)
5,993
(26.5)
3,416
(15.2)
2,328
(10.4)
3,045
(13.7)
5,555
(25.0)
11,123
(50.3)
11,489
(52.3)
5,354
(24.6)
2,470
(11.4)
5 1,325,949
(14.5)
413
(3.1)
1,230
(9.3)
955
(7.3)
605
(4.6)
1,217
(9.3)
1,007
(7.8)
1,095
(8.5)
3,058
(23.7)
8,438
(65.8)
7,528
(59.2)
4,576
(36.3)
2,187
(17.5)
1,436
(11.5)
6 1,194,444
(13.1)
459
(3.8)
658
(5.5)
486
(4.1)
1,744
(14.7)
4,019
(34.1)
1,687
(14.4)
1,206
(10.3)
2,161
(18.6)
4,403
(38.0)
6,419
(55.7)
6,182
(54.0)
2,338
(20.6)
1,104
(9.8)
7 458,363
(5.0)
58
(1.3)
238
(5.2)
250
(5.5)
221
(4.9)
600
(13.3)
681
(15.2)
853
(19.1)
1,432
(32.2)
3,652
(82.6)
3,057
(69.8)
2,007
(46.2)
935
(21.7)
465
(10.9)
8 374,484
(4.1)
74
(2.0)
208
(5.6)
179
(4.8)
147
(4.0)
277
(7.5)
241
(6.5)
414
(11.3)
1,100
(30.1)
2,568
(70.6)
1,908
(52.8)
992
(27.7)
515
(14.4)
369
(10.4)
9 1,041,079
(11.4)
164
(1.6)
387
(3.7)
344
(3.3)
1,376
(13.3)
2,356
(22.9)
967
(9.5)
627
(6.2)
860
(8.5)
3,112
(30.7)
7,725
(76.6)
6,059
(60.6)
2,253
(22.8)
875
(8.9)
10 418,702
(4.6)
44
(1.1)
133
(3.2)
92
(2.2)
145
(3.5)
387
(9.3)
290
(7.0)
221
(5.4)
438
(10.7)
1,103
(27.0)
1,266
(31.1)
767
(18.9)
462
(11.4)
312
(7.8)
Urban versus rural
Rural 4,469,258
(49.0)
579
(1.3)
1,870
(4.2)
1,623
(3.7)
2,955
(6.7)
6,872
(15.6)
4,680
(10.7)
4,147
(9.5)
7,468
(17.2)
17,506
(40.4)
23,772
(55.1)
19,440
(45.4)
8,734
(20.6)
4,513
(10.7)
Urban 4,658,415
(51.0)
1,891
(4.1)
5,476
(11.8)
3,334
(7.2)
4,679
(10.2)
9,233
(20.1)
4,509
(9.9)
3,379
(7.4)
6,055
(13.4)
16,047
(35.6)
23,585
(52.5)
19,991
(44.8)
8,964
(20.3)
4,744
(10.8)
BMI (kg/m2)
<18.5 (underweight) 64,634
(0.7)
38
(5.9)
148
(23.5)
101
(16.4)
95
(15.7)
115
(19.3)
98
(16.7)
74
(12.8)
105
(18.4)
223
(39.6)
374
(66.9)
367
(66.4)
159
(29.4)
89
(16.6)
18.5 to <25 (normal weight) 1,841,422
(20.2)
413
(2.2)
1,448
(7.9)
1,030
(5.7)
1,218
(6.7)
2,414
(13.4)
1,362
(7.6)
1,171
(6.6)
1,864
(10.5)
4,658
(26.5)
6,929
(39.5)
5,908
(33.9)
2,703
(15.7)
1,345
(7.8)
25 to <30 (overweight) 3,314,997
(36.3)
794
(2.4)
2,348
(7.1)
1,602
(4.9)
2,509
(7.7)
5,183
(15.9)
2,920
(9.0)
2,460
(7.6)
4,410
(13.6)
10,898
(33.9)
15,526
(48.4)
12,829
(40.3)
5,759
(18.2)
2,928
(9.3)
30 to <35 (obese I) 2,433,428
(26.7)
677
(2.8)
1,901
(7.8)
1,260
(5.2)
2,181
(9.0)
4,684
(19.5)
2,679
(11.2)
2,163
(9.1)
3,969
(16.7)
9,903
(41.7)
13,689
(57.9)
11,498
(49.0)
5,096
(21.9)
2,744
(11.8)
35 to <40 (obese II) 1,026,570
(11.2)
355
(3.5)
946
(9.2)
633
(6.2)
1,039
(10.2)
2,358
(23.2)
1,398
(13.8)
1,031
(10.2)
2,007
(20.0)
4,995
(49.9)
6,941
(69.7)
5,696
(57.6)
2,540
(25.9)
1,371
(14.1)
≥40 (obese III) 446,622
(4.9)
193
(4.3)
555
(12.5)
331
(7.5)
592
(13.4)
1,351
(30.6)
732
(16.7)
627
(14.3)
1,168
(26.8)
2,876
(66.3)
3,898
(90.6)
3,133
(73.5)
1,441
(34.2)
780
(18.6)
CCI
0 to 1 6,063,266
(66.4)
955
(1.6)
2,620
(4.3)
1,805
(3.0)
3,799
(6.3)
7,918
(13.2)
4,197
(7.0)
3,313
(5.5)
6,130
(10.3)
15,701
(26.4)
21,571
(36.3)
17,532
(29.7)
8,062
(13.7)
4,708
(8.0)
2 to 3 1,520,767
(16.7)
552
(3.6)
1,649
(10.9)
1,154
(7.7)
1,575
(10.5)
3,703
(24.8)
2,093
(14.1)
1,813
(12.3)
3,253
(22.2)
7,929
(54.3)
11,334
(78.1)
9,722
(67.7)
4,332
(30.5)
2,198
(15.6)
4 to 5 768,966
(8.4)
346
(4.5)
1,153
(15.1)
807
(10.7)
985
(13.1)
1,990
(26.6)
1,301
(17.5)
1,073
(14.6)
1,815
(24.8)
4,613
(63.4)
6,557
(90.9)
5,671
(79.5)
2,427
(34.6)
1,110
(15.9)
≥6 774,674
(8.5)
617
(8.0)
1,924
(25.2)
1,191
(15.8)
1,275
(17.1)
2,494
(33.8)
1,598
(21.9)
1,327
(18.4)
2,325
(32.7)
5,310
(75.5)
7,895
(113.4)
6,506
(94.9)
2,877
(42.9)
1,241
(18.7)

* VA enrollees at risk are those who are still alive and not yet infected at the beginning of each time period.

Categorized according to the 10 US Federal Regions drawn up by the Office of Management and Budget: 1 (CT, MA, ME, NH, RI, and VT), 2 (NJ, NY, PR, and Virgin Island), 3 (DC, DE, MD, PA, VA, and WV), 4 (AL, FL, GA, KY, MS, NC, SC, and TN), 5 (IL, IN, MI, MN, OH, and WI), 6 (AR, LA, NM, OK, and TX), 7 (IA, KS, MO, and NE), 8 (CO, MT, ND, SD, UT, and WY), 9 (AZ, CA, GU, HI, and NV), and 10 (AK, ID, OR, and WA).

AI/AN, American Indian/Alaska Native; CCI, Charlson comorbidity index; PI/NH, Pacific Islander/Native Hawaiian; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; VA, Veterans Affairs.